Topics

Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019

20:00 EDT 1 May 2019 | Globe Newswire

BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday May 6th, 2019 to discuss the 1st  quarter 2019 financial results and business update.

The Company invites you to listen to the call by dialing (866) 393-8366.  International participants should call (409) 350-3154.  Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:       
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com 

Teligent.jpg

NEXT ARTICLE

More From BioPortfolio on "Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...